Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

RX-3117

Catalog No. T16813Cas No. 865838-26-2
Alias TV-1360, fluorocyclopentenylcytosine

RX-3117 (fluorocyclopentenylcytosine) is a novel a cytidine analog. RX-3117 displays anticancer activity in several cancer cell lines, including gemcitabine-resistant variants.

RX-3117

RX-3117

Purity: 99.55%
Catalog No. T16813Alias TV-1360, fluorocyclopentenylcytosineCas No. 865838-26-2
RX-3117 (fluorocyclopentenylcytosine) is a novel a cytidine analog. RX-3117 displays anticancer activity in several cancer cell lines, including gemcitabine-resistant variants.
Pack SizePriceAvailabilityQuantity
1 mg$159In Stock
2 mg$223In Stock
5 mg$326In Stock
10 mg$467In Stock
25 mg$767In Stock
50 mg$1,070In Stock
100 mg$1,450In Stock
1 mL x 10 mM (in DMSO)$336In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "RX-3117"

Select Batch
Purity:99.55%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
RX-3117 (fluorocyclopentenylcytosine) is a novel a cytidine analog. RX-3117 displays anticancer activity in several cancer cell lines, including gemcitabine-resistant variants.
In vitro
RX-3117 was a very poor substrate for cytidine deaminase (66,000-fold less than gemcitabine). RX-3117 showed a different sensitivity profile compared to cyclopentenyl-cytosine and azacytidine, substrates for uridine-cytidine-kinase. Insensitive U937 cells 1 μM RX-3117 resulted in 90% inhibition of RNA synthesis but 100 μM RX-3117 was required in A2780 and CCRF-CEM cells. RX-3117 at IC50 values did not affect the integrity of RNA [1].
In vivo
RX-3117 (p.o.) was examined in 9 different human tumor xenograft models grown subcutaneously in athymic nude mice. In the Colo 205, H460, H69 and CaSki models, gemcitabine treatment resulted in 28%, 30%, 25% and 0% tumor growth inhibition (TGI), respectively. Whereas oral treatment with RX-3117 induced 100%, 78%, 62% and 66% TGI, respectively [2].
AliasTV-1360, fluorocyclopentenylcytosine
Chemical Properties
Molecular Weight257.22
FormulaC10H12FN3O4
Cas No.865838-26-2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (194.39 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.8877 mL19.4386 mL38.8772 mL194.3861 mL
5 mM0.7775 mL3.8877 mL7.7754 mL38.8772 mL
10 mM0.3888 mL1.9439 mL3.8877 mL19.4386 mL
20 mM0.1944 mL0.9719 mL1.9439 mL9.7193 mL
50 mM0.0778 mL0.3888 mL0.7775 mL3.8877 mL
100 mM0.0389 mL0.1944 mL0.3888 mL1.9439 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy RX-3117 | purchase RX-3117 | RX-3117 cost | order RX-3117 | RX-3117 chemical structure | RX-3117 in vivo | RX-3117 in vitro | RX-3117 formula | RX-3117 molecular weight